Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001330434 | SCV001522114 | uncertain significance | Combined oxidative phosphorylation defect type 20 | 2019-12-10 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Mayo Clinic Laboratories, |
RCV002261342 | SCV002542160 | uncertain significance | not provided | 2021-09-17 | criteria provided, single submitter | clinical testing |